Early Day Motion·EDM 142
AVAILABILITY OF GLIVEC
23 November 200417 Signatures
Motion Text
That this House supports the guidance issued by the Department of Health ensuring that Glivec, a novel treatment for chronic myeloid leukaemia, is available on the NHS; and calls on NICE to recognise this without restrictions on this drug.